Patients' concerns about clinical trials in Japan.
Aoki
E
E
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D035061:Control Groups; D003520:Cyclophosphamide / Q000008:administration & dosage; D030881:Disclosure; D015251:Epirubicin / Q000008:administration & dosage; D026724:Ethical Review; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007258:Informed Consent; D012107:Research Design; D005641:Tegafur / Q000627:therapeutic use*; D036302:Therapeutic Human Experimentation
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D005641:Tegafur; D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil